SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
FRA:SRT3 - Deutsche Boerse Ag - DE0007165631 - Currency: EUR
Taking everything into account, SRT3 scores 3 out of 10 in our fundamental rating. SRT3 was compared to 19 industry peers in the Life Sciences Tools & Services industry. SRT3 may be in some trouble as it scores bad on both profitability and health. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SRT3 had positive earnings in the past year.
In the past year SRT3 had a positive cash flow from operations.
SRT3 had positive earnings in each of the past 5 years.
SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SRT3 has a Return On Assets of 0.94%. This is in the lower half of the industry: SRT3 underperforms 68.42% of its industry peers.
SRT3 has a worse Return On Equity (3.52%) than 63.16% of its industry peers.
SRT3 has a Return On Invested Capital of 3.51%. This is in the lower half of the industry: SRT3 underperforms 73.68% of its industry peers.
SRT3 had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 7.38%.
The last Return On Invested Capital (3.51%) for SRT3 is well below the 3 year average (8.34%), which needs to be investigated, but indicates that SRT3 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.94% | ||
| ROE | 3.52% | ||
| ROIC | 3.51% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT3 (2.77%) is worse than 68.42% of its industry peers.
SRT3's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 11.82%, SRT3 is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SRT3 has declined.
With a decent Gross Margin value of 45.27%, SRT3 is doing good in the industry, outperforming 73.68% of the companies in the same industry.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.82% | ||
| PM (TTM) | 2.77% | ||
| GM | 45.27% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SRT3 is creating some value.
The number of shares outstanding for SRT3 has been increased compared to 1 year ago.
The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
SRT3 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.23 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SRT3 (2.23) is worse than 63.16% of its industry peers.
SRT3 has a debt to FCF ratio of 6.50. This is a slightly negative value and a sign of low solvency as SRT3 would need 6.50 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.50, SRT3 is doing worse than 68.42% of the companies in the same industry.
A Debt/Equity ratio of 1.55 is on the high side and indicates that SRT3 has dependencies on debt financing.
SRT3 has a worse Debt to Equity ratio (1.55) than 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.5 | ||
| Altman-Z | 2.23 |
ROIC/WACC0.46
WACC7.66%
2.3 Liquidity
A Current Ratio of 1.46 indicates that SRT3 should not have too much problems paying its short term obligations.
SRT3 has a Current ratio (1.46) which is in line with its industry peers.
SRT3 has a Quick Ratio of 1.46. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT3 has a Quick ratio of 0.93. This is in the lower half of the industry: SRT3 underperforms 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
SRT3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.23%.
Measured over the past years, SRT3 shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
The Revenue has been growing slightly by 3.99% in the past year.
SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)-36.23%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%30.97%
Revenue 1Y (TTM)3.99%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%7.74%
3.2 Future
SRT3 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.27% yearly.
The Revenue is expected to grow by 8.50% on average over the next years. This is quite good.
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue Next Year6.37%
Revenue Next 2Y7.98%
Revenue Next 3Y8.7%
Revenue Next 5Y8.5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 51.83 indicates a quite expensive valuation of SRT3.
SRT3's Price/Earnings ratio is a bit more expensive when compared to the industry. SRT3 is more expensive than 68.42% of the companies in the same industry.
When comparing the Price/Earnings ratio of SRT3 to the average of the S&P500 Index (27.30), we can say SRT3 is valued expensively.
The Price/Forward Earnings ratio is 34.88, which means the current valuation is very expensive for SRT3.
68.42% of the companies in the same industry are cheaper than SRT3, based on the Price/Forward Earnings ratio.
SRT3's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.83 | ||
| Fwd PE | 34.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SRT3 is valued a bit more expensive than 63.16% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as SRT3.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.26 | ||
| EV/EBITDA | 24.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SRT3's earnings are expected to grow with 26.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.26
PEG (5Y)N/A
EPS Next 2Y24.43%
EPS Next 3Y26.21%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, SRT3 is not a good candidate for dividend investing.
SRT3's Dividend Yield is comparable with the industry average which is at 0.72.
Compared to an average S&P500 Dividend Yield of 2.37, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
53.09% of the earnings are spent on dividend by SRT3. This is a bit on the high side, but may be sustainable.
The dividend of SRT3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.09%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
FRA:SRT3 (7/9/2025, 1:28:07 PM)
221.3
-0.9 (-0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.57B
Analysts77.14
Price Target360.76 (63.02%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP53.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.1%
Min EPS beat(2)-4.13%
Max EPS beat(2)-4.06%
EPS beat(4)1
Avg EPS beat(4)-0.94%
Min EPS beat(4)-22.4%
Max EPS beat(4)26.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.77%
Min Revenue beat(2)2.67%
Max Revenue beat(2)4.87%
Revenue beat(4)3
Avg Revenue beat(4)1.54%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.85%
PT rev (3m)-2.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.86%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.83 | ||
| Fwd PE | 34.88 | ||
| P/S | 4.81 | ||
| P/FCF | 23.26 | ||
| P/OCF | 15.49 | ||
| P/B | 6.12 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.5 |
EPS(TTM)4.27
EY1.93%
EPS(NY)6.35
Fwd EY2.87%
FCF(TTM)9.51
FCFY4.3%
OCF(TTM)14.29
OCFY6.46%
SpS45.99
BVpS36.19
TBVpS-35.83
PEG (NY)2.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.94% | ||
| ROE | 3.52% | ||
| ROCE | 4.72% | ||
| ROIC | 3.51% | ||
| ROICexc | 3.9% | ||
| ROICexgc | 12.82% | ||
| OM | 11.82% | ||
| PM (TTM) | 2.77% | ||
| GM | 45.27% | ||
| FCFM | 20.68% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.5 | ||
| Debt/EBITDA | 5.06 | ||
| Cap/Depr | 84.42% | ||
| Cap/Sales | 10.39% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 128.78% | ||
| Profit Quality | 745.86% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 2.23 |
F-Score7
WACC7.66%
ROIC/WACC0.46
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.23%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%30.97%
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue 1Y (TTM)3.99%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%7.74%
Revenue Next Year6.37%
Revenue Next 2Y7.98%
Revenue Next 3Y8.7%
Revenue Next 5Y8.5%
EBIT growth 1Y-9.05%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year103.14%
EBIT Next 3Y38.58%
EBIT Next 5Y26.99%
FCF growth 1Y303.11%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y44.89%
OCF growth 3Y4.07%
OCF growth 5Y20.79%